DUBLIN--(BUSINESS WIRE)--The "Global
Single Cell Analysis Market - Segmented by Cell type, Technique,
Application, End-User and Geography - Growth, Trends, and Forecast (2018
- 2023)" report has been added to ResearchAndMarkets.com's
offering.
The single cell analysis market is expected to grow at a CAGR of about
17% during the forecast period.
Growth of the market is primarily driven by the technological
advancements in single-cell analysis products, increasing government
funding for cell-based research, growing biotechnology and
pharmaceutical industries, wide applications of single-cell analysis in
cancer research, growing focus on personalized medicine, and increasing
incidence and prevalence of chronic and infectious diseases.
Growing Investments in Cancer Research
The rise in acquired resistance against systemic therapies is constantly
happening due to the generation of variant cancer cells which leads to,
the inability to cure advanced cancer patients. Circulating tumor cells
are gaining increasing clinical attention because they may enable the
monitoring cancer progression and adjustment of treatment.
Implementation of technologies like single cell analysis in standardized
and automated workflows in clinical diagnostics could provide valuable
information for real-time monitoring of cancer and eventually new
therapeutic strategies for the benefit of patients. This will lead to
the growth of this market.
Other factors that will lead this market to grow include technological
advancements in single-cell analysis products, growing biotechnology and
biopharmaceutical industries, wide applications of single-cell analysis
in cancer research, growing focus on personalized medicine and
increasing incidence and prevalence of chronic and infectious diseases.
Other Key Highlights
-
High Cost of Single-Cell Analysis Products
-
Asia-Pacific to Emerge as the Fastest Growing Region
Notable Development in the Market
-
Single-Cell RNA Sequencing Reveals Neuronal Diversity. Using a new
approach to analyze the transcriptomes of thousands of individual cell
nuclei in postmortem brains, researchers identify multiple neuronal
subtypes.
Companies Featured
-
Agilent Technologies
-
Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)
-
Becton, Dickinson & Company
-
Bio-Rad Laboratories Inc.
-
Fluidigm Corporation
-
GE Healthcare
-
Illumina Inc.
-
Merck KGaA
-
Qiagen N.V.
-
Thermo Fisher Scientific Inc.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/vpd8zt/global_single?w=4
